Download PDF
J Knee Surg 2022; 35(04): 362-366
DOI: 10.1055/s-0040-1715098
Original Article

Gout As a Predictor of Total Knee Arthroplasty Outcomes and Costs

Samuel Rosas  ‡   *
1   Department of Orthopaedic Surgery, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina
,
Andrey Zuskov‡   *
1   Department of Orthopaedic Surgery, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina
,
Tianyi David Luo
1   Department of Orthopaedic Surgery, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina
,
Martin W. Roche
2   Department of Orthopedic Surgery, Holy Cross Orthopedic Institute, Fort Lauderdale, Florida
,
Cynthia L. Emory
1   Department of Orthopaedic Surgery, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina
,
Johannes F. Plate
1   Department of Orthopaedic Surgery, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Gout is the most common inflammatory arthritis and affects approximately 4% of the U.S. population. As the prevalence of gout and the number of total knee arthroplasties (TKAs) performed continue to increase, the literature on TKA in patients with gout remains scant. The purpose of this study was to evaluate the outcomes of patients with gout following TKA at a population level, that is, how patient with gout fair after TKA. We hypothesized that patients with gout have higher rates of complications and higher costs compared with controls. A case–control study was designed to evaluate two cohorts of Medicare patients who underwent TKA whose only distinguishing feature was the presence or absence of gout. Matching was performed to decrease confounding at a 1:1 ratio based on age, gender, and Charlson comorbidity index (CCI), (10-year survival predictor). The Medicare standard analytical files were queried through International Classification of Disease and current procedural terminology codes. A total of 15,238 patients were evaluated with 7,619 in each cohort. There were no age, gender, or CCI differences and 57.4% were females. Day of surgery and 90-day post-surgery costs were both significantly greater in those with gout (p < 0.001 for both). Multivariate analysis revealed that gout patients had increased odds of infection (odds ratio [OR] 1.229, p = 0.019), cardiac arrest (OR 1.354, p = 0.002), pneumonia (OR 1.161, p < 0.001), hematoma (OR 1.204, p = 0.002), and development of capsulitis (OR 1.208, p = 0.012). Nonetheless these patients had a decreased risk of pulmonary emboli (OR 0.835, p = 0.016). Our results support our hypothesis that patients with gout have higher rates of postoperative complications and increased day of surgery and 90-day costs of care after TKA. Given the high prevalence of gout in the United States, additional study on the utility of preoperative gout optimization for TKA patients is warranted. The level of evidence of this study is III, and it is a retrospective case–control study.

Keywords

gout - arthroplasty - costs - Charlson comorbidity index

* Samuel Rosas, MD, MBA and Andrey Zuskov, MD contributed equally to the writing of this manuscript.




Publication History

Received: 06 May 2020

Accepted: 25 June 2020

Article published online:
24 August 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Roddy E, Choi HK. Epidemiology of gout. Rheum Dis Clin North Am 2014; 40 (02) 155-175
    CrossrefPubMedGoogle Scholar
  • 2 Inacio MCS, Paxton EW, Graves SE, Namba RS, Nemes S. Projected increase in total knee arthroplasty in the United States—an alternative projection model. Osteoarthritis Cartilage 2017; 25 (11) 1797-1803
    CrossrefPubMedGoogle Scholar
  • 3 Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet 2016; 388 (10055): 2039-2052
    CrossrefPubMedGoogle Scholar
  • 4 Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63 (10) 3136-3141
    CrossrefPubMedGoogle Scholar
  • 5 Dalbeth N, Clark B, Gregory K. et al. Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography. Ann Rheum Dis 2009; 68 (08) 1290-1295
    CrossrefPubMedGoogle Scholar
  • 6 Dalbeth N, Aati O, Kalluru R. et al. Relationship between structural joint damage and urate deposition in gout: a plain radiography and dual-energy CT study. Ann Rheum Dis 2015; 74 (06) 1030-1036
    CrossrefPubMedGoogle Scholar
  • 7 Buck M, Delaney M. Diagnosis and management of gout in total knee arthroplasty. Orthop Nurs 2014; 33 (01) 37-40 , quiz 41–42
    CrossrefPubMedGoogle Scholar
  • 8 Chen F, Glezos C, Blum Y, Hossack M, Schwechter EM. Nonsurgical treatment of aseptic periprosthetic gout flare of the knee: a report of 2 cases. JBJS Case Connect 2016; 6 (04) e93
    CrossrefPubMedGoogle Scholar
  • 9 Zadaka A, Gioe T, Gertner E. Acute crystal-induced arthritis following arthroplasty. J Knee Surg 2010; 23 (01) 17-20
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Soloway S. Tophaceous gout in a knee with total joint replacement. J Clin Rheumatol 2011; 17 (01) 48
    CrossrefPubMedGoogle Scholar
  • 11 Freehill MT, McCarthy EF, Khanuja HS. Total knee arthroplasty failure and gouty arthropathy. J Arthroplasty 2010; 25 (04) 658.e7-658.e10
    CrossrefPubMedGoogle Scholar
  • 12 Chen C-L, Shao H, Block JL, Chen AF. Greater wound and renal complications in gout patients undergoing total joint arthroplasty. J Arthroplasty 2016; 31 (07) 1431-1436
    CrossrefPubMedGoogle Scholar
  • 13 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (05) 373-383
    CrossrefPubMedGoogle Scholar
  • 14 Menendez ME, Neuhaus V, van Dijk CN, Ring D. The Elixhauser comorbidity method outperforms the Charlson index in predicting inpatient death after orthopaedic surgery. Clin Orthop Relat Res 2014; 472 (09) 2878-2886
    CrossrefPubMedGoogle Scholar
  • 15 Bjorgul K, Novicoff WM, Saleh KJ. Evaluating comorbidities in total hip and knee arthroplasty: available instruments. J Orthop Traumatol 2010; 11 (04) 203-209
    CrossrefPubMedGoogle Scholar
  • 16 Chuang S-Y, Lee S-C, Hsieh Y-T, Pan W-H. Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008. Asia Pac J Clin Nutr 2011; 20 (02) 301-308
    PubMedGoogle Scholar
  • 17 Singh JA. When gout goes to the heart: does gout equal a cardiovascular disease risk factor?. Ann Rheum Dis 2015; 74 (04) 631-634
    CrossrefPubMedGoogle Scholar
  • 18 Salt E, Wiggins AT, Rayens MK. et al. Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis. Semin Arthritis Rheum 2017; 46 (04) 423-429
    CrossrefPubMedGoogle Scholar
  • 19 Ma C-Y, Lu YD, Bell KL. et al. Predictors of treatment failure after 2-stage reimplantation for infected total knee arthroplasty: a 2- to 10-year follow-up. J Arthroplasty 2018; 33 (07) 2234-2239
    CrossrefPubMedGoogle Scholar
  • 20 Flores NM, Nuevo J, Klein AB, Baumgartner S, Morlock R. The economic burden of uncontrolled gout: how controlling gout reduces cost. J Med Econ 2019; 22 (01) 1-6
    CrossrefPubMedGoogle Scholar
  • 21 Lee Y-Y, Tang C-H, Chen J-H, Kuo L-N, Ko Y. Evaluation of healthcare costs and utilization for patients with gout: a population-based matched cohort study. Curr Med Res Opin 2018; 34 (04) 735-740
    CrossrefPubMedGoogle Scholar
  • 22 Lee Y-Y, Kuo LN, Chen JH, Lin YC, Chen LF, Ko Y. Prescribing patterns and healthcare costs of gout. Curr Med Res Opin 2019; 35 (06) 1051-1058
    CrossrefPubMedGoogle Scholar
  • 23 Li L, McCormick N, Sayre EC. et al. Trends of venous thromboembolism risk before and after diagnosis of gout: a general population-based study. Rheumatology (Oxford) 2020; 59 (05) 1099-1107
    CrossrefPubMedGoogle Scholar
  • 24 Chiu C-C, Chen YT, Hsu CY. et al. Association between previous history of gout attack and risk of deep vein thrombosis—a nationwide population-based cohort study. Sci Rep 2016; 6: 26541
    CrossrefPubMedGoogle Scholar
  • 25 Huang C-C, Huang PH, Chen JH. et al. An independent risk of gout on the development of deep vein thrombosis and pulmonary embolism: a nationwide, population-based cohort study. Medicine (Baltimore) 2015; 94 (51) e2140
    CrossrefPubMedGoogle Scholar
  • 26 Watson DJ, Rhodes T, Cai B, Guess HA. Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis. Arch Intern Med 2002; 162 (10) 1105-1110
    CrossrefPubMedGoogle Scholar
  • 27 Memtsoudis SG. Limitations associated with the analysis of data from administrative databases. Anesthesiology 2009; 111 (02) 449 , author reply 450–451
    CrossrefPubMedGoogle Scholar
  • 28 Bohl DD, Basques BA, Golinvaux NS, Baumgaertner MR, Grauer JN. Nationwide inpatient sample and national surgical quality improvement program give different results in hip fracture studies. Clin Orthop Relat Res 2014; 472 (06) 1672-1680
    CrossrefPubMedGoogle Scholar
  • 29 Patel AA, Singh K, Nunley RM, Minhas SV. Administrative databases in orthopaedic research: pearls and pitfalls of big data. J Am Acad Orthop Surg 2016; 24 (03) 172-179
    CrossrefPubMedGoogle Scholar
  • 30 Alluri RK, Leland H, Heckmann N. Surgical research using national databases. Ann Transl Med 2016; 4 (20) 393
    CrossrefPubMedGoogle Scholar